Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |